
First in the US
An FDA authorization in 2025.
In September 2025 the FDA authorized Essilor Stellest lenses to correct nearsightedness and slow its progression in children who start between ages 6 and 12.
Myopia control glasses
Some new eyeglass lenses correct a child's blur through the center while tiny features around it send a signal meant to slow eye growth. No contact lenses or drops needed.


First in the US
In September 2025 the FDA authorized Essilor Stellest lenses to correct nearsightedness and slow its progression in children who start between ages 6 and 12.
Good fit for
Glasses suit younger children and families who prefer not to use lenses or drops. Your doctor still measures progress at each visit.
Most kids get used to the lenses quickly.
Prescription and eye length are tracked over time.
Some lenses are sold abroad or still being studied in the US.

Wear it well
Doctors encourage full-day wear in a frame that stays centered. Outdoor play time and breaks from close-up screens are healthy habits too.
Simple care helps lenses stay clear and centered.
Search near you and ask whether the practice offers myopia control glasses.
Yes. The FDA granted marketing authorization in September 2025 for children 6 to 12 at the start of treatment.
No. Standard single-vision lenses correct blur but are not designed to slow progression.
Ask your doctor about sports frames or a backup plan for active play.
Other designs exist. As of October 2026 they were not FDA authorized for slowing myopia in the US.
Yes. Progress checks show whether the plan is working.
This page is for general education and is not medical advice. Only an eye doctor who has examined your child can recommend a myopia control plan. Stellest is a trademark of Essilor.